Iridex (IRIX) Current Deferred Tax Assets (2015)

Iridex (IRIX) recorded quarterly Current Deferred Tax Assets of $1.6 million in Q4 2015, little changed quarter-over-quarter from $1.6 million in Q3 2015.

Iridex (IRIX) Current Deferred Tax Assets (2015) Analysis & Trends

Iridex's Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $1.6 million for Q4 2015.

  • In Q4 2015, Current Deferred Tax Assets changed N/A year-over-year to $1.6 million; the TTM figure through Oct 2015 stood at $1.6 million (changed N/A YoY), while the FY2015 annual figure was $1.6 million, changed N/A from the prior year.
  • Current Deferred Tax Assets was $1.6 million for Q4 2015 at Iridex, roughly flat from $1.6 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $1.6 million in Q1 2015 to a low of $1.6 million in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Iridex 19.91 Mn 15.31 Mn 4.74 Mn

Historic Data

Download Data
DateValue
Oct 3, 2015 1.63 Mn
Oct 3, 2015 1.63 Mn
Jul 4, 2015 1.63 Mn
Jul 4, 2015 1.63 Mn
Apr 4, 2015 1.63 Mn
Apr 4, 2015 1.63 Mn
Jan 3, 2015 1.63 Mn
Jan 3, 2015 1.63 Mn